HER2-Positive Gastric Adenocarcinoma
HER2-positive gastric adenocarcinoma is a subtype of stomach cancer characterized by the overexpression of the HER2 (human epidermal growth factor receptor 2) protein. This aggressive…
HER2-Negative and CLDN18.2-Positive Gastric
Gastric and gastroesophageal junction (GEJ) adenocarcinomas are aggressive malignancies with limited treatment options. Recent advancements have identified CLDN18.2 as a promising biomarker in patients with…